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When observing the medical and health situation in the world, 
diabetes, obesity and metabolic syndrome have been crucial social 
problems in developed and also developing countries [1]. Especially, 
the diet therapy would be indispensable which can be continued for 
long years such as low carbohydrate diet (LCD) and Calorie restriction 
(CR). LCD was originally begun by Atkins and Bernstein before, and 
it has been known and popular until now. [2, 3]. 
After that, there was a meaningful report from Dietary Intervention 
Randomized Controlled Trial (DIRECT) Group that showed the 
predominance compared with Mediterranean and Low-Fat Diet for 2 
years [4]. Successively, DIRECT group reported the results for 4 years 
[5]. Thus, several researchers reported the predominance of LCD for 
weight reduction or HbA1c value [6].
 In contrast, authors and colleagues have introduced and 
developed LCD in Japan for long years [7]. We have continued 
practice and research of LCD and activities of Japan LCD promotion 
association, including educational seminars, medical journals / books 
and presenting in medical society [8]. 
There has been lots of discussion about LCD and CR for years. 
LCD has rather superiority to CR diets and low-fat foods in the light of 
weight control and blood glucose variety in short period [4]. For more 
than 1 year or more, continuing discussion has found concerning the 
comparison of LCD and CR [9]. Some reports showed beneficial effect 
of LCD and others revealed unremarkable difference between them 
[6, 10, 11].
There is a prospective randomized controlled trial (RCT) that 
LCD of 130g /day for 6 months reduced HbA1c and BMI more than 
CR [12]. However, the benefit for LCD after intensive intervention 
has not always maintained in the light of HbA1c and BMI between 
LCD and CR. This study was continued and summarized one year 
after regarding the comparison between LCD and CR. The result 
showed the beneficial efficacy for the LCD on reduction of HbA1c and 
BMI, but improved levels did not persist compared with that of CR. 
However, when combined the data of both groups, HbA1c and BMI 
values were significantly decreased from the baseline. The superiority 
of LCD seemed to disappear 1 year after, but those results would 
suggest the comparative efficacy to improve HbA1c value at least 1 
year [12]. 
As described above, the discussion of the clinical effect for LCD 
and CR has been continued for long years. However, we cannot 
induce the final conclusion which is superior. They are various factors 
involved in the evaluation and measurement of the both methods. 
The research has been not in vitro research or in vivo study of the 
same feeds to rat every day, but clinical meal study for human in their 
ordinary daily life. 
In the primary care setting, general efficacy of LCD has been 
understood rather widely. On the other hand, a problem has been 
known about whether the LCD continuation is possible, or whether 
the effect of weight reduction is possible during rather long period. 
After a while, some patients return to their previous meal style [13]. 
There are some reports that the effect of LCD can be sustained rather 
long term [14]. Since there are various influential factors, it will be 
necessary to investigate related influence into detail analysis [15]. 
 A recent report was found that revealed several results against the 
previous clinical effect for LCD. There has been the Atherosclerosis 
Risk in Communities (ARIC) Study which has continued its research 
development for some decades [16]. The ARIC study has many subjects 
more than 430 thousand for 25 years [17]. According to the results of 
ARIC cohort study, they have reported a U-shaped association between 
the percentage of energy of carbohydrate (mean 48·9%, SD 9·4) and 
mortality, after calculating for multivariable adjustment. Furthermore, 
they calculated and compared the total carbohydrate ratio of the diet. 
As a result, daily meal including high (>70%) percentage or low 
(<40%) percentage of energy from carbohydrates were observed, in 
association with elevated mortality rate, and with minimal risk found 
between carbohydrate content ratio in 50–55% [17]. 
In order to evaluate the optimal intake amount of carbohydrate 
for the guidance recommendations associated with certain medical 
evidence, the protocol included the population-based study of 
overall carbohydrate consumption [17]. Especially, it investigated 
the association of carbohydrate intake amount in accordance with 
mortality and residual lifespan levels. As a daily meal method, LCD was 
applied for reducing body weight and decreasing the cardiovascular 
and metabolic risk. At the same time, they recommended to replace 
of carbohydrate food with other proteins and plant-based fats. This 
procedure can give the subjects practical approach for daily healthy 
life in the light of anti-aging medicine [17]. 
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In the practice and research on diabetes, how should we think 
about the relationship between clinical matters and the Evidence-
Based Medicine (EBM)? [18] EBM has not only critically examined 
evidence, but also considered practicality, reality and individual tastes 
and situations. Short-term LCD has been effective by conventional 
reports and may increase the motivation feeling for progressive cure 
and care for the patients [19]. However, on the other hand, for long-
term LCD, we have to consider the required daily calorie and also 
carbohydrate intake amount. Based on this situation, we would like 
to aim for Taylor-made diet therapy according to each patient, taking 
account of feasibility, continuity and safety [20, 21]. 
 In summary, the discussion on the comparison of LCD and CR 
has been continued for years. The main point would be the clinical 
efficacy for rather long term. Each report includes each definition of 
LCD such as the different amount or ratio of carbohydrate in the food. 
Consequently, further accumulation of the data would be expected for 
future practice and research development. 
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